Term Insurance Market Is Expected To Grow At 8.8% CAGR With Reaching a Market Value Of USD 2,601.2 Bn By 2033, : Dimension Market Research
10 sept. 2024 11h13 HE
|
Dimension Market Research
New York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Global Term Insurance Market size is expected to reach USD 1,215.0 billion by 2024 and is further anticipated to reach USD 2,601.2 billion by 2033...
Precision Medicine Market Is Expected To Reach Revenue Of USD 225.7 Bn By 2033, At 11.6% CAGR: Dimension Market Research
10 sept. 2024 11h03 HE
|
Dimension Market Research
New York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global Precision Medicine Market is to reach USD 83.9 billion by 2024 and is further anticipated to reach USD 225.7 billion by 2033...
Hint Health and Tendo Care Connect Join Forces to Enhance Employer Healthcare Offerings
10 sept. 2024 10h15 HE
|
Tendo Systems Inc.
Tendo Care Connect and Hint Connect Bring Affordable, Bundled Direct Healthcare Solutions to Employers
Study Finds Cylinder Digital Health Platform Significantly Improves Digestive Health Symptoms
10 sept. 2024 10h00 HE
|
Cylinder
Study Finds Cylinder Digital Health Platform Significantly Improves Digestive Health Symptoms
SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board
10 sept. 2024 08h30 HE
|
SS Innovations
SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board
Gingival Recession Treatment Market is Projected to Grow at a 5.4% CAGR, Hitting US$ 5.38 Billion by 2034 | Fact.MR Report
10 sept. 2024 07h00 HE
|
FACT.MR
Rockville, MD , Sept. 10, 2024 (GLOBE NEWSWIRE) -- The global Gingival Recession Treatment Market is projected to reach US$ 5.38 billion by the end of 2034, up from US$ 3.18 billion in 2024,...
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
10 sept. 2024 06h57 HE
|
Aclarion, Inc.
Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled Trial...
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
09 sept. 2024 15h50 HE
|
Enovis Corporation
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the...
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
09 sept. 2024 09h31 HE
|
Halberd Corp.
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
College of Professional Studies at Syracuse University and MedCerts Collaborate to Offer Innovative Education and Career Development Opportunities
09 sept. 2024 09h00 HE
|
MedCerts
SYRACUSE, N.Y., Sept. 09, 2024 (GLOBE NEWSWIRE) -- The College of Professional Studies at Syracuse University and MedCerts proudly announce a new partnership focused on delivering innovative,...